Dulaglutide
Trulicity
- Molecular form
- GLP-1 analog–Fc fusion protein
GLP-1 analog–Fc fusion protein
Open the sources to check how the studies were done and what they can support.
A long-acting GLP-1 receptor agonist built as an Fc fusion protein, with large randomized cardiovascular-outcome research in type 2 diabetes.
- Family
- GLP-1 fusion protein
- Research target
- GLP-1 receptor
- Molecular form
- GLP-1 analog–Fc fusion protein
What to know about the research
REWIND studied clinical outcomes in a defined diabetes population. It is distinct from a short biomarker or receptor-activation experiment.
Check the exact compound
The complete molecule includes linked GLP-1 analog and Fc regions. A simple short-peptide residue count would misrepresent its structure.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries